Expense Ratio Rating
6 /10
Expense Rating
1 /10
Market Score
4 /10
Category Score
8 /10
Market Size
4 /10
$SBIYX Alternatives
Different Funds
We found 9,471 International Stocks Large Value funds. Here they are ordered by FI Score.
- lsaf
- ETF
- US Stocks
- Large Blend
LeaderSharesTM AlphaFactor US Core Equity ETF
Expenses: 0.75% (Better than 1% of similar funds)
This is a bad choice for a Large Blend US Stocks fund. See why »
- pfcdx
- Mutual Fund
- US Stocks
- Large Blend
Pacific Funds Large-Cap Advisor Class
Expenses: 0.67% (Better than 1% of similar funds)
This is a bad choice for a Large Blend US Stocks fund. See why »
- buy
- ETF
- US Stocks
- Small Value
USCF SummerHaven SHPEI Index Fund
Expenses: 0.80% (Better than 1% of similar funds)
This is a bad choice for a Small Value US Stocks fund. See why »
- bxdcx
- Mutual Fund
- Bond
- High Yield Bond
Barings Active Short Duration Bond Fund Class C
Expenses: 0.90% (Better than 1% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
- qrsvx
- Mutual Fund
- US Stocks
- Small Value
Queens Road Small Cap Value Fund
Expenses: 1.18% (Better than 1% of similar funds)
This is a bad choice for a Small Value US Stocks fund. See why »
- centx
- Mutual Fund
- Allocation
- Total World
Centerstone Investors Fund Class I
Expenses: 1.10% (Better than 1% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- orscx
- Mutual Fund
- Bond
- Municipal Bond
Invesco Oppenheimer Short Term Municipal Fund Class C
Expenses: 1.57% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- pxwgx
- Mutual Fund
- US Stocks
- Large Blend
Pax ESG Beta Quality Fund Individual Investor Class
Expenses: 0.90% (Better than 0% of similar funds)
This is a bad choice for a Large Blend US Stocks fund. See why »
- cmcax
- Mutual Fund
- Commodities
- Broad
VanEck CM Commodity Index Fund Class A
Expenses: 0.95% (Better than 1% of similar funds)
This is a bad choice for a Broad Commodities fund. See why »
- cncr
- ETF
- Sector Equity
- Healthcare
Loncar Cancer Immunotherapy ETF
Expenses: 0.79% (Better than 1% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
- aggrx
- Mutual Fund
- Allocation
- Total World
American Century Focused Global Growth Fund A Class
Expenses: 1.32% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- asfcx
- Mutual Fund
- Alternatives
- Future
AlphaSimplex Managed Futures Strategy Fund Class C
Expenses: 2.45% (Better than 0% of similar funds)
This is a bad choice for a Future Alternatives fund. See why »
- baplx
- Mutual Fund
- Allocation
- Target-Date
BlackRock LifePath® Smart Beta 2055 Fund Investor A Shares
Expenses: 0.35% (Better than 1% of similar funds)
This is a bad choice for a Target-Date Allocation fund. See why »
- dglcx
- Mutual Fund
- Allocation
- Total World
BNY Mellon Global Stock Fund - Class C
Expenses: 1.96% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- btpix
- Mutual Fund
- Alternatives
- Short
Salient Tactical Plus Fund Class F
Expenses: 1.09% (Better than 1% of similar funds)
This is a bad choice for a Short Alternatives fund. See why »
- caycx
- Mutual Fund
- Bond
- Municipal Bond
American Century California High Yield Municipal Fund Class C
Expenses: 1.50% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
- crarx
- Mutual Fund
- Alternatives
- Real Estate
MainStay CBRE Real Estate Fund Class I
Expenses: 0.91% (Better than 1% of similar funds)
This is a bad choice for a Real Estate Alternatives fund. See why »
- csmix
- Mutual Fund
- US Stocks
- Small Value
Columbia Small Cap Value Fund I Class A
Expenses: 1.32% (Better than 0% of similar funds)
This is a bad choice for a Small Value US Stocks fund. See why »
- bbc
- ETF
- Sector Equity
- Healthcare
Virtus LifeSci Biotech Clinical Trials ETF
Expenses: 0.79% (Better than 1% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »